1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Alcon, Inc.

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.
David J. Endicott

rue Louis-d'Affry 6


Alcon downgraded to hold at Societe Generale on macro headwinds
Aug 11, 2022 16:33pm

Societe Generale has downgraded Alcon (ALC) to hold from buy as the eye care companys immunity to macro headwinds is declining.

Source:Seeking Alpha
UPDATE: Societe Generale Downgrades Alcon Inc. to Hold, ''immunity to macro headwinds lessens''
Aug 11, 2022 16:10pm
Kala Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Aug 11, 2022 11:00am

-- Plan to Initiate Phase 2/3 Trial of KPI-012 for Persistent Corneal Epithelial Defect (PCED) in 4Q 2022; Topline Data Expected in 1Q 2024 -- -- Received $60M Upfront Payment from Sale of EYSUVIS® and INVELTYS® to Alcon Inc. and Significantly Reduced Operating Expenses, Extending Cash Runway into 2Q 2024 -- -- Conference Call and Webcast at 8:00 a.m. ET -- ARLINGTON, Mass., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare diseases of the eye, today reported financial results for the second quarter ended June 30, 2022 and provided a corporate update.

Trading - Axon, Trade Desk rise; Alcon, Rackspace fall
Aug 10, 2022 20:29pm

NEW YORK - Stocks that traded heavily or had substantial price changes Wednesday: Alcon Inc., down $3.53 to $71.94. The eye care company trimmed its profit and revenue…

Source:Business Mag
Axon, Trade Desk rise; Alcon, Rackspace fall
Aug 10, 2022 20:13pm

Stocks that traded heavily or had substantial price changes Wednesday: Axon, Trade Desk rise; Alcon, Rackspace fall

Source:ABC News
Why Is Alcon Inc. (NYSE: ALC) Falling?
Aug 10, 2022 18:00pm

Alcon Inc. (NYSE:ALC) traded at $72.00 at close of the session on Wednesday, August 10, made a downward move of -4.60% on its previous day’s price. Looking at the stock we see that its previous close was $75.47 and the beta (5Y monthly) reads 0.62 with the day’s price range being $75.35 – $76.06. The … Why Is Alcon Inc. (NYSE: ALC) Falling? Read More »

Source:Stocks Register
Alcon Inc. (ALC) CEO David Endicott on Q2 2022 Results - Earnings Call Transcript
Aug 10, 2022 16:43pm

Alcon Inc. (NYSE:NYSE:ALC) Q2 2022 Results Conference Call August 10, 2022 08:00 AM ET Company Participants Dan Cravens - VP and Global Head IR David Endicott - CEO Tim Stonesifer - CFO…

Source:Seeking Alpha
Alcon: Q2 Earnings Insights
Aug 10, 2022 03:11am

Alcon (NYSE: ALC ) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here''s what investors need to know about the announcement. Earnings Alcon beat estimated earnings by 28.57%, reporting an EPS of $0.63 versus an estimate of $0.49. Revenue was up $106.00 million from the same period last … Full story available on

Alcon Non-GAAP EPS of $0.63 beats by $0.07, revenue of $2.2B in-line, cuts FY22 guidance
Aug 09, 2022 20:35pm

Alcon press release (ALC): Q2 Non-GAAP EPS of $0.63 beats by $0.07.Revenue of $2.2B (+5.3% Y/Y) in-line.FY22 Guidance:Net Sales of $8.6B-$8.8B from prior outlook of $8.7 to $8.9…

Source:Seeking Alpha
Alcon Reports Second Quarter 2022 Results
Aug 09, 2022 20:30pm

GENEVA--(BUSINESS WIRE)--Alcon Reports Second Quarter 2022 Results

Source:Business Wire
Here’s why peak inflation might not signal the end of the bear market in stocks
Aug 09, 2022 10:40am

Howdy markets people. Phil Rosen here in Los Angeles. Officially, I''m a senior reporter, but I''m tempted to change my title to "Bear Whisperer" because that''s really what I spend much of my time doing lately. I''ve been reading bleak market forecasts and talking to pessimistic analysts at a higher clip than usual, and I''ve really honed an eye for bears. Today I''m breaking down what two top banks expect to happen on the Street in the coming months — one of which doesn''t see the bear market ending soon. If this was forwarded to you, sign up here . Download Insider''s app here. 1. It''s too premature to call the end to the stock downturn, according to Morgan Stanley. Inflation may have peaked, but that doesn''t mean equities are going to see any relief , analysts wrote in a Monday note. Companies are faced with the two-pronged challenge of falling prices and high labor costs, which weighs on profits and sets a trap for investors. "The rally in stocks has been powerful , and has many investors believing the bear market is over ," Morgan Stanley analysts said.

Source:Business Insider Nederlands
Earnings Preview For Alcon
Aug 08, 2022 18:04pm

Alcon (NYSE: ALC ) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here''s what investors need to know before the announcement. Analysts estimate that Alcon will report an earnings per share (EPS) of $0.49. Alcon bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on

Financial Markets Today: Quick Take – August 8, 2022
Aug 08, 2022 06:28am

Equity markets were churned by the July US jobs report on Friday, first falling sharply as treasury yields jolted higher on the day, but later rallying back to close the day only modestly lower. The US yield curve is about 10 basis points from its most dramatic inversion since 1982 as the market eyes an incoming recession despite the strong US jobs data and July ISM Services data last week. This week’s chief data focus is the Wednesday US July CPI data release. What is our trading focus? Nasdaq 100 (USNAS100.I) and S&P 500 (US500.I). US equity markets saw a very choppy session on Friday as interest-rate sensitive growth stocks dipped sharply on the strong July US jobs report. The broader market recovered most of the lost ground intra-day, but performance across themes was very mixed, with our Energy Storage basket the best performer among our “theme baskets”, likely on the passage of the climate bill by the US Senate (more below). Earnings season is winding down for the quarter, but a few prominent names are set to report this week, including Walt Disney on Wednesday.

Source:SAXO Group
Ciba Vision Johor Sdn. Bhd. also known as ALCON Johor earns the best place to work certification in Malaysia for the second year in row
Jul 06, 2022 12:34pm

KUALA LUMPUR, Malaysia , July 6, 2022 /PRNewswire/ -- Alcon Johor an affiliate of the largest eye care device company in the world with 75 years heritage, present in over 70 countries and serving patients in more than 140 countries by over 23,000 associates, has been recently recognized as one of the best places to work for in Malaysia for the second consecutive year. This acknowledges Alcon''s commitment towards fostering an environment and culture of respect, pride amongst its employees. According to the company results, 95% of the employees said it''s a great workplace compared to 79% in a typical company in Malaysia . It is a great feeling to be recognized as the Best Place to Work second year in a row. We are profoundly honored and humbled to receive this recognition; at Alcon, we are deliberate in creating a conducive environment that promotes our culture, where our associates are valued, recognized, and rewarded. We couldn''t have achieved this without the trust and belief of our associates.

Source:PR Newswire Asia (English)
If You Purchased Certain Disposable Contact Lenses for Your Own Use From June 1, 2013 to December 4, 2018, this Litigation and Two Class Action Settlements Could Affect Your Rights.
Jun 23, 2022 12:00pm

JACKSONVILLE, Fla., June 23, 2022 /PRNewswire/ -- The following statement is being issued regarding In re Disposable Contact Lens Antitrust Litigation. Two class action settlements have been reached with Alcon Vision LLC f/k/a Alcon Laboratories, Inc. ("Alcon") and Johnson & Johnson…

Source:PR Newswire